Stephanie B. Hastings, Ph.D.
Scientist, Assay Development, Translational Genomics
Stephanie B. Hastings, Ph.D., is an assay development scientist in Translational Genomics at Q2 Solutions | EA Genomics. In this role, she is responsible for the development and validation of genomic assays to support research and clinical programs. Stephanie is currently leading development efforts surrounding liquid biopsy applications, including circulating-tumor DNA (ctDNA) and circulating-tumor cells (CTCs).

Stephanie has more than 10 years of experience across diverse disciplines including: clinical molecular diagnostics, animal health vaccine development, genetic engineering and protein biochemistry.

Stephanie earned a Bachelors degree in Microbiology from North Carolina State University, followed by a Ph.D. in Biochemistry and Molecular Biology at the University of Georgia.

Updated as of September 2018.